Experiments for taxon Sarcococca saligna (BUXACEAE)

150 experiments

Experiment	Worktypes	Pharmacology	Organism (specimen)	Compound
286123	PHARMACOLOGY OF COMPOUND - IN VITRO	ACETYLCHOLINESTERASE INHIBITION	Sarcococca saligna (BUXACEAE)	PACHYSAMINE,EPI: 2-BETA-HYDROXY:
220621	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Sarcococca saligna (BUXACEAE)	PACHYSAMINE D,N-A-METHYL-EPI:
286134	ISOLATION AND IDENTIFICATION OF		Sarcococca saligna (BUXACEAE)	AXILLARINE C
286149	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTICRUSTACEAN ACTIVITY	Sarcococca saligna (BUXACEAE)	SARACODINE,N(3)-DEMETHYL:
312761	PHARMACOLOGY OF COMPOUND - IN VITRO	BUTYRYLCHOLINESTERASE INHIBITION	Sarcococca saligna (BUXACEAE)	PACHYSAMINE D,EPI:
215110	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Sarcococca saligna (BUXACEAE)	PREGNA-5-14-DIEN-4-ONE,20(S)-(N-N-DIMETHYL-AMINO)-3-BETA-(2-METHYL-BUT-CIS-2-ENAMIDO):
213941	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDVOUCHER SPECIMEN REPORTED FORCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Sarcococca saligna (BUXACEAE)	SALIGNONE,TRANS:
220626	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Sarcococca saligna (BUXACEAE)	PACHYSAMINE D,N-A-METHYL-EPI:
194505	MEDICINAL FOLKLORE REPORTED FOR	ANTIINFLAMMATORY ACTIVITY	Sarcococca saligna (BUXACEAE)
312772	PHARMACOLOGY OF COMPOUND - IN VITRO	ACETYLCHOLINESTERASE INHIBITION	Sarcococca saligna (BUXACEAE)	ALKALOID C
220625	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Sarcococca saligna (BUXACEAE)	PACHYSAMINE D,N-A-METHYL-EPI:
215109	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDVOUCHER SPECIMEN REPORTED FORCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Sarcococca saligna (BUXACEAE)	PREGN-5-EN-4-ONE,20(S)-(N-N-DIMETHYL-AMINO)-3-BETA-(METHYL-BUT-CIS-2-ENAMIDO):
286118	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Sarcococca saligna (BUXACEAE)	SALIGNENAMIDE D
286129	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTICRUSTACEAN ACTIVITY	Sarcococca saligna (BUXACEAE)	SALIGNENAMIDE E
286127	PHARMACOLOGY OF COMPOUND - IN VITRO	ACETYLCHOLINESTERASE INHIBITION	Sarcococca saligna (BUXACEAE)	SALIGNENAMIDE E
286156	PHARMACOLOGY OF COMPOUND - IN VITRO	BUTYRYLCHOLINESTERASE INHIBITION	Sarcococca saligna (BUXACEAE)	SALIGNENAMIDE A
286145	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTICRUSTACEAN ACTIVITY	Sarcococca saligna (BUXACEAE)	SARCORINE
286162	ISOLATION AND IDENTIFICATION OF		Sarcococca saligna (BUXACEAE)	AXILLARIDINE A
312750	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Sarcococca saligna (BUXACEAE)	SALONINE C
286138	ISOLATION AND IDENTIFICATION OF		Sarcococca saligna (BUXACEAE)	AXILLARINE F
220614	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Sarcococca saligna (BUXACEAE)	SALIGCINNAMIDE
286163	PHARMACOLOGY OF COMPOUND - IN VITRO	ACETYLCHOLINESTERASE INHIBITION	Sarcococca saligna (BUXACEAE)	AXILLARIDINE A
286120	PHARMACOLOGY OF COMPOUND - IN VITRO	BUTYRYLCHOLINESTERASE INHIBITION	Sarcococca saligna (BUXACEAE)	SALIGNENAMIDE D
301091	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Sarcococca saligna (BUXACEAE)	SALONINE B
205797	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF		Sarcococca saligna (BUXACEAE)	SARACOCINE
286153	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTICRUSTACEAN ACTIVITY	Sarcococca saligna (BUXACEAE)	SALIGCINNAMIDE
219049	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Sarcococca saligna (BUXACEAE)	SALIGNENAMIDE B
286131	PHARMACOLOGY OF COMPOUND - IN VITRO	ACETYLCHOLINESTERASE INHIBITION	Sarcococca saligna (BUXACEAE)	SALIGNENAMIDE F
219050	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Sarcococca saligna (BUXACEAE)	PACHYSAMINE D,2-4-DIACETOXY-EPI:
312759	ISOLATION AND IDENTIFICATION OF		Sarcococca saligna (BUXACEAE)	PACHYSAMINE D,EPI:
312748	PHARMACOLOGY OF COMPOUND - IN VITRO	ACETYLCHOLINESTERASE INHIBITION	Sarcococca saligna (BUXACEAE)	SALIGNARINE F
286142	ISOLATION AND IDENTIFICATION OF		Sarcococca saligna (BUXACEAE)	SARCORINE
301095	PHARMACOLOGY OF COMPOUND - IN VITRO	ACETYLCHOLINESTERASE INHIBITION	Sarcococca saligna (BUXACEAE)	ALKALOID C
205794	PMR SPECTRUM REPORTEDVOUCHER SPECIMEN REPORTED FORCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Sarcococca saligna (BUXACEAE)	SARCONIDINE
312737	PHARMACOLOGY OF COMPOUND - IN VITRO	BUTYRYLCHOLINESTERASE INHIBITION	Sarcococca saligna (BUXACEAE)	SALIGNARINE E,2-HYDROXY:
194506	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF		Sarcococca saligna (BUXACEAE)	SARACODINE
286116	PHARMACOLOGY OF COMPOUND - IN VITRO	BUTYRYLCHOLINESTERASE INHIBITION	Sarcococca saligna (BUXACEAE)	SALIGNENAMIDE C
220615	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Sarcococca saligna (BUXACEAE)	SALIGCINNAMIDE
286168	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTICRUSTACEAN ACTIVITY	Sarcococca saligna (BUXACEAE)	SARSALIGNONE
312769	PHARMACOLOGY OF COMPOUND - IN VITRO	ACETYLCHOLINESTERASE INHIBITION	Sarcococca saligna (BUXACEAE)	SARCODININE
194503	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Sarcococca saligna (BUXACEAE)	SARACOCINAENE
205796	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF		Sarcococca saligna (BUXACEAE)	PACHYSANDRINE A,EPI:
1201371	PHARMACOLOGY OF EXTRACT - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ANTIMITOTIC ACTIVITY	Sarcococca saligna (BUXACEAE)
286159	PHARMACOLOGY OF COMPOUND - IN VITRO	ACETYLCHOLINESTERASE INHIBITION	Sarcococca saligna (BUXACEAE)	VAGANINE A
312756	ISOLATION AND IDENTIFICATION OF		Sarcococca saligna (BUXACEAE)	DICTYOPHLEBINE
312751	PHARMACOLOGY OF COMPOUND - IN VITRO	ACETYLCHOLINESTERASE INHIBITION	Sarcococca saligna (BUXACEAE)	SALONINE C
220611	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDVOUCHER SPECIMEN REPORTED FORCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Sarcococca saligna (BUXACEAE)	SALIGCINNAMIDE
286166	PHARMACOLOGY OF COMPOUND - IN VITRO	ACETYLCHOLINESTERASE INHIBITION	Sarcococca saligna (BUXACEAE)	SARSALIGNONE
301090	PHARMACOLOGY OF COMPOUND - IN VITRO	BUTYRYLCHOLINESTERASE INHIBITION	Sarcococca saligna (BUXACEAE)	SALONINE A
312740	PHARMACOLOGY OF COMPOUND - IN VITRO	BUTYRYLCHOLINESTERASE INHIBITION	Sarcococca saligna (BUXACEAE)	SARCONIDINE,5-6-DIHYDRO:
312762	ISOLATION AND IDENTIFICATION OF		Sarcococca saligna (BUXACEAE)	SARCOSINE
286115	PHARMACOLOGY OF COMPOUND - IN VITRO	ACETYLCHOLINESTERASE INHIBITION	Sarcococca saligna (BUXACEAE)	SALIGNENAMIDE C
312745	PHARMACOLOGY OF COMPOUND - IN VITRO	ACETYLCHOLINESTERASE INHIBITION	Sarcococca saligna (BUXACEAE)	SALIGNAMINE,2-HYDROXY:
258513	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDVOUCHER SPECIMEN REPORTED FORCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Sarcococca saligna (BUXACEAE)	SALIGNARINE A
286161	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTICRUSTACEAN ACTIVITY	Sarcococca saligna (BUXACEAE)	VAGANINE A
220622	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Sarcococca saligna (BUXACEAE)	PACHYSAMINE D,N-A-METHYL-EPI:
312767	PHARMACOLOGY OF COMPOUND - IN VITRO	BUTYRYLCHOLINESTERASE INHIBITION	Sarcococca saligna (BUXACEAE)	CHONEMORPHINE,ISO-N-FORMYL:
312747	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Sarcococca saligna (BUXACEAE)	SALIGNARINE F
312736	PHARMACOLOGY OF COMPOUND - IN VITRO	ACETYLCHOLINESTERASE INHIBITION	Sarcococca saligna (BUXACEAE)	SALIGNARINE E,2-HYDROXY:
213943	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Sarcococca saligna (BUXACEAE)	SARACODINE,N(A)-DEMETHYL:
312758	PHARMACOLOGY OF COMPOUND - IN VITRO	BUTYRYLCHOLINESTERASE INHIBITION	Sarcococca saligna (BUXACEAE)	DICTYOPHLEBINE
286143	PHARMACOLOGY OF COMPOUND - IN VITRO	ACETYLCHOLINESTERASE INHIBITION	Sarcococca saligna (BUXACEAE)	SARCORINE
312771	ISOLATION AND IDENTIFICATION OF		Sarcococca saligna (BUXACEAE)	ALKALOID C
286126	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Sarcococca saligna (BUXACEAE)	SALIGNENAMIDE E
286137	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTICRUSTACEAN ACTIVITY	Sarcococca saligna (BUXACEAE)	AXILLARINE C
220618	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Sarcococca saligna (BUXACEAE)	SALIGCINNAMIDE
194507	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF		Sarcococca saligna (BUXACEAE)	PACHYAXIMINE A
286148	PHARMACOLOGY OF COMPOUND - IN VITRO	BUTYRYLCHOLINESTERASE INHIBITION	Sarcococca saligna (BUXACEAE)	SARACODINE,N(3)-DEMETHYL:
286132	PHARMACOLOGY OF COMPOUND - IN VITRO	BUTYRYLCHOLINESTERASE INHIBITION	Sarcococca saligna (BUXACEAE)	SALIGNENAMIDE F
286121	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTICRUSTACEAN ACTIVITY	Sarcococca saligna (BUXACEAE)	SALIGNENAMIDE D
258516	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Sarcococca saligna (BUXACEAE)	SALIGNARINE D
286154	ISOLATION AND IDENTIFICATION OF		Sarcococca saligna (BUXACEAE)	SALIGNENAMIDE A
301094	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION AND IDENTIFICATION OF		Sarcococca saligna (BUXACEAE)	ALKALOID C
286169	PHARMACOLOGY OF COMPOUND - IN VITRO	ACETYLCHOLINESTERASE INHIBITION	Sarcococca saligna (BUXACEAE)	SARSALIGNENONE
258514	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Sarcococca saligna (BUXACEAE)	SALIGNARINE B
286147	PHARMACOLOGY OF COMPOUND - IN VITRO	ACETYLCHOLINESTERASE INHIBITION	Sarcococca saligna (BUXACEAE)	SARACODINE,N(3)-DEMETHYL:
286160	PHARMACOLOGY OF COMPOUND - IN VITRO	BUTYRYLCHOLINESTERASE INHIBITION	Sarcococca saligna (BUXACEAE)	VAGANINE A
220612	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Sarcococca saligna (BUXACEAE)	SALIGCINNAMIDE
258517	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Sarcococca saligna (BUXACEAE)	SALIGNARINE E
312744	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Sarcococca saligna (BUXACEAE)	SALIGNAMINE,2-HYDROXY:
312746	PHARMACOLOGY OF COMPOUND - IN VITRO	BUTYRYLCHOLINESTERASE INHIBITION	Sarcococca saligna (BUXACEAE)	SALIGNAMINE,2-HYDROXY:
286165	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTICRUSTACEAN ACTIVITY	Sarcococca saligna (BUXACEAE)	AXILLARIDINE A
312741	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Sarcococca saligna (BUXACEAE)	SALIGNAMINE
286171	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTICRUSTACEAN ACTIVITY	Sarcococca saligna (BUXACEAE)	SARSALIGNENONE
220623	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Sarcococca saligna (BUXACEAE)	PACHYSAMINE D,N-A-METHYL-EPI:
205795	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Sarcococca saligna (BUXACEAE)	SARCORINE
286158	ISOLATION AND IDENTIFICATION OF		Sarcococca saligna (BUXACEAE)	VAGANINE A
312752	PHARMACOLOGY OF COMPOUND - IN VITRO	BUTYRYLCHOLINESTERASE INHIBITION	Sarcococca saligna (BUXACEAE)	SALONINE C
312763	PHARMACOLOGY OF COMPOUND - IN VITRO	ACETYLCHOLINESTERASE INHIBITION	Sarcococca saligna (BUXACEAE)	SARCOSINE
312757	PHARMACOLOGY OF COMPOUND - IN VITRO	ACETYLCHOLINESTERASE INHIBITION	Sarcococca saligna (BUXACEAE)	DICTYOPHLEBINE
312755	PHARMACOLOGY OF COMPOUND - IN VITRO	BUTYRYLCHOLINESTERASE INHIBITION	Sarcococca saligna (BUXACEAE)	ALONINE B,N-[FORMYL(METHYL)-AMINO]:
286140	PHARMACOLOGY OF COMPOUND - IN VITRO	BUTYRYLCHOLINESTERASE INHIBITION	Sarcococca saligna (BUXACEAE)	AXILLARINE F
312735	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDVOUCHER SPECIMEN REPORTED FORCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Sarcococca saligna (BUXACEAE)	SALIGNARINE E,2-HYDROXY:
286114	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Sarcococca saligna (BUXACEAE)	SALIGNENAMIDE C
220617	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Sarcococca saligna (BUXACEAE)	SALIGCINNAMIDE
286136	PHARMACOLOGY OF COMPOUND - IN VITRO	BUTYRYLCHOLINESTERASE INHIBITION	Sarcococca saligna (BUXACEAE)	AXILLARINE C
220628	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Sarcococca saligna (BUXACEAE)	PACHYSAMINE D,EPI:
286144	PHARMACOLOGY OF COMPOUND - IN VITRO	BUTYRYLCHOLINESTERASE INHIBITION	Sarcococca saligna (BUXACEAE)	SARCORINE
301093	PHARMACOLOGY OF COMPOUND - IN VITRO	BUTYRYLCHOLINESTERASE INHIBITION	Sarcococca saligna (BUXACEAE)	SALONINE B
286125	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTICRUSTACEAN ACTIVITY	Sarcococca saligna (BUXACEAE)	PACHYSAMINE,EPI: 2-BETA-HYDROXY:
312739	PHARMACOLOGY OF COMPOUND - IN VITRO	ACETYLCHOLINESTERASE INHIBITION	Sarcococca saligna (BUXACEAE)	SARCONIDINE,5-6-DIHYDRO:
286150	ISOLATION AND IDENTIFICATION OF		Sarcococca saligna (BUXACEAE)	SALIGCINNAMIDE
286155	PHARMACOLOGY OF COMPOUND - IN VITRO	ACETYLCHOLINESTERASE INHIBITION	Sarcococca saligna (BUXACEAE)	SALIGNENAMIDE A
286133	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTICRUSTACEAN ACTIVITY	Sarcococca saligna (BUXACEAE)	SALIGNENAMIDE F
301088	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDVOUCHER SPECIMEN REPORTED FORCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Sarcococca saligna (BUXACEAE)	SALONINE A
1074830	PHARMACOLOGY OF EXTRACT - IN VITRO	PROTEIN SYNTHESIS INHIBITION	Sarcococca saligna (BUXACEAE)
213942	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Sarcococca saligna (BUXACEAE)	SALIGNONE,CIS:
312770	PHARMACOLOGY OF COMPOUND - IN VITRO	BUTYRYLCHOLINESTERASE INHIBITION	Sarcococca saligna (BUXACEAE)	SARCODININE
286122	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Sarcococca saligna (BUXACEAE)	PACHYSAMINE,EPI: 2-BETA-HYDROXY:
312766	PHARMACOLOGY OF COMPOUND - IN VITRO	ACETYLCHOLINESTERASE INHIBITION	Sarcococca saligna (BUXACEAE)	CHONEMORPHINE,ISO-N-FORMYL:
220620	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Sarcococca saligna (BUXACEAE)	PACHYSAMINE D,N-A-METHYL-EPI:
286128	PHARMACOLOGY OF COMPOUND - IN VITRO	BUTYRYLCHOLINESTERASE INHIBITION	Sarcococca saligna (BUXACEAE)	SALIGNENAMIDE E
312742	PHARMACOLOGY OF COMPOUND - IN VITRO	ACETYLCHOLINESTERASE INHIBITION	Sarcococca saligna (BUXACEAE)	SALIGNAMINE
286135	PHARMACOLOGY OF COMPOUND - IN VITRO	ACETYLCHOLINESTERASE INHIBITION	Sarcococca saligna (BUXACEAE)	AXILLARINE C
312743	PHARMACOLOGY OF COMPOUND - IN VITRO	BUTYRYLCHOLINESTERASE INHIBITION	Sarcococca saligna (BUXACEAE)	SALIGNAMINE
312768	ISOLATION AND IDENTIFICATION OF		Sarcococca saligna (BUXACEAE)	SARCODININE
219048	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDVOUCHER SPECIMEN REPORTED FORCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Sarcococca saligna (BUXACEAE)	SALIGNENAMIDE A
215111	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF		Sarcococca saligna (BUXACEAE)	CHONEMORPHINE,N-FORMYL:
312754	PHARMACOLOGY OF COMPOUND - IN VITRO	ACETYLCHOLINESTERASE INHIBITION	Sarcococca saligna (BUXACEAE)	ALONINE B,N-[FORMYL(METHYL)-AMINO]:
220613	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Sarcococca saligna (BUXACEAE)	SALIGCINNAMIDE
286164	PHARMACOLOGY OF COMPOUND - IN VITRO	BUTYRYLCHOLINESTERASE INHIBITION	Sarcococca saligna (BUXACEAE)	AXILLARIDINE A
312773	PHARMACOLOGY OF COMPOUND - IN VITRO	BUTYRYLCHOLINESTERASE INHIBITION	Sarcococca saligna (BUXACEAE)	ALKALOID C
312753	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Sarcococca saligna (BUXACEAE)	ALONINE B,N-[FORMYL(METHYL)-AMINO]:
220624	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Sarcococca saligna (BUXACEAE)	PACHYSAMINE D,N-A-METHYL-EPI:
286139	PHARMACOLOGY OF COMPOUND - IN VITRO	ACETYLCHOLINESTERASE INHIBITION	Sarcococca saligna (BUXACEAE)	AXILLARINE F
312764	PHARMACOLOGY OF COMPOUND - IN VITRO	BUTYRYLCHOLINESTERASE INHIBITION	Sarcococca saligna (BUXACEAE)	SARCOSINE
286157	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTICRUSTACEAN ACTIVITY	Sarcococca saligna (BUXACEAE)	SALIGNENAMIDE A
286119	PHARMACOLOGY OF COMPOUND - IN VITRO	ACETYLCHOLINESTERASE INHIBITION	Sarcococca saligna (BUXACEAE)	SALIGNENAMIDE D
286170	PHARMACOLOGY OF COMPOUND - IN VITRO	BUTYRYLCHOLINESTERASE INHIBITION	Sarcococca saligna (BUXACEAE)	SARSALIGNENONE
258515	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Sarcococca saligna (BUXACEAE)	SALIGNARINE C
286146	ISOLATION AND IDENTIFICATION OF		Sarcococca saligna (BUXACEAE)	SARACODINE,N(3)-DEMETHYL:
286152	PHARMACOLOGY OF COMPOUND - IN VITRO	BUTYRYLCHOLINESTERASE INHIBITION	Sarcococca saligna (BUXACEAE)	SALIGCINNAMIDE
286151	PHARMACOLOGY OF COMPOUND - IN VITRO	ACETYLCHOLINESTERASE INHIBITION	Sarcococca saligna (BUXACEAE)	SALIGCINNAMIDE
286141	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTICRUSTACEAN ACTIVITY	Sarcococca saligna (BUXACEAE)	AXILLARINE F
220619	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Sarcococca saligna (BUXACEAE)	PACHYSAMINE D,N-A-METHYL-EPI:
301092	PHARMACOLOGY OF COMPOUND - IN VITRO	ACETYLCHOLINESTERASE INHIBITION	Sarcococca saligna (BUXACEAE)	SALONINE B
312738	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Sarcococca saligna (BUXACEAE)	SARCONIDINE,5-6-DIHYDRO:
220616	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Sarcococca saligna (BUXACEAE)	SALIGCINNAMIDE
301096	PHARMACOLOGY OF COMPOUND - IN VITRO	BUTYRYLCHOLINESTERASE INHIBITION	Sarcococca saligna (BUXACEAE)	ALKALOID C
286167	PHARMACOLOGY OF COMPOUND - IN VITRO	BUTYRYLCHOLINESTERASE INHIBITION	Sarcococca saligna (BUXACEAE)	SARSALIGNONE
286124	PHARMACOLOGY OF COMPOUND - IN VITRO	BUTYRYLCHOLINESTERASE INHIBITION	Sarcococca saligna (BUXACEAE)	PACHYSAMINE,EPI: 2-BETA-HYDROXY:
312760	PHARMACOLOGY OF COMPOUND - IN VITRO	ACETYLCHOLINESTERASE INHIBITION	Sarcococca saligna (BUXACEAE)	PACHYSAMINE D,EPI:
312765	ISOLATION AND IDENTIFICATION OF		Sarcococca saligna (BUXACEAE)	CHONEMORPHINE,ISO-N-FORMYL:
301089	PHARMACOLOGY OF COMPOUND - IN VITRO	ACETYLCHOLINESTERASE INHIBITION	Sarcococca saligna (BUXACEAE)	SALONINE A
220627	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF		Sarcococca saligna (BUXACEAE)	PACHYSAMINE D,EPI:
286117	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTICRUSTACEAN ACTIVITY	Sarcococca saligna (BUXACEAE)	SALIGNENAMIDE C
312749	PHARMACOLOGY OF COMPOUND - IN VITRO	BUTYRYLCHOLINESTERASE INHIBITION	Sarcococca saligna (BUXACEAE)	SALIGNARINE F
194504	MEDICINAL FOLKLORE REPORTED FOR	ANTIPYRETIC ACTIVITY	Sarcococca saligna (BUXACEAE)
215112	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF		Sarcococca saligna (BUXACEAE)	VAGANINE A
286130	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Sarcococca saligna (BUXACEAE)	SALIGNENAMIDE F

Experiments for taxon Sarcococca saligna (BUXACEAE)

Experiments (150 results)

Filters

Worktypes (14)

Pharmacology (9)

Compounds (51)

Organisms (12)